bluebird raises $30 million

bluebird bio Inc. (Cambridge, Mass.) raised $30 million in a series C round. New investor Arch Venture Partners joined existing investors Third Rock Ventures; TVM Capital; Forbion Capital Partners; and Easton Capital Investment in the round. Arch's Steven Gillis will join bluebird's board. ...